Arkolith/Insider Trading/BTTX/Form 4

Armanino Andrew J.

DirectorBetter Therapeutics, Inc. (BTTX) · full profile →Form 4 · filed Jun 10, 2022
Net Buying
Open-Market Buys
$41K
Open-Market Sells
$0
Net Open-Market Flow
$41K
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 9, 2022Buy(P)25K$1.65$41K151K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 9, 2022Grant(A)15K—$015K

Transaction Codes

P
Open-market purchase
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-22-021934) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML